ProfileGDS4718 / 226839_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 78% 71% 75% 76% 72% 84% 87% 78% 73% 76% 74% 72% 82% 84% 86% 79% 75% 84% 87% 81% 75% 75% 75% 78% 77% 83% 76% 82% 78% 86% 81% 84% 70% 75% 83% 80% 86% 75% 76% 75% 77% 84% 77% 85% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]7.5814278
GSM549102patient 115, normal, homogenized [OPG study]6.9080171
GSM549104patient 119, normal, homogenized [OPG study]7.4005875
GSM549108patient 138, normal, homogenized [OPG study]7.3203676
GSM549119patient 077, normal, homogenized [OPG study]7.0068972
GSM549133patient 032, cancer, homogenized [OPG study]8.5189984
GSM549139patient 042, cancer, homogenized [OPG study]8.693787
GSM549099patient 107, normal, homogenized [OPG study]7.570978
GSM549109patient 139, normal, homogenized [OPG study]7.0960173
GSM549110patient 046, normal, homogenized [OPG study]7.3649676
GSM549114patient 063, normal, homogenized [OPG study]7.2794474
GSM549122patient 082, normal, homogenized [OPG study]7.0264972
GSM549134patient 033, cancer, homogenized [OPG study]8.1403282
GSM549136patient 036, cancer, homogenized [OPG study]8.4633484
GSM549140patient 044, cancer, homogenized [OPG study]8.6567186
GSM549111patient 047, normal, homogenized [OPG study]7.7953379
GSM549113patient 057, normal, homogenized [OPG study]7.398875
GSM549132patient 031, cancer, homogenized [OPG study]8.3754284
GSM549137patient 038, cancer, homogenized [OPG study]8.7857387
GSM549142patient 047, cancer, homogenized [OPG study]7.6706381
GSM549100patient 110, normal, homogenized [OPG study]7.3031375
GSM549107patient 135, normal, homogenized [OPG study]7.3828575
GSM549115patient 068, normal, homogenized [OPG study]7.4218275
GSM549116patient 072, normal, homogenized [OPG study]7.6256378
GSM549120patient 078, normal, homogenized [OPG study]7.5581177
GSM549131patient 030, cancer, homogenized [OPG study]8.3308683
GSM549118patient 074, normal, homogenized [OPG study]7.4320676
GSM549129patient 027, cancer, homogenized [OPG study]8.131782
GSM549123patient 088, normal, homogenized [OPG study]7.5920778
GSM549124patient 006, cancer, homogenized [OPG study]8.4301786
GSM549126patient 015, cancer, homogenized [OPG study]7.995481
GSM549128patient 025, cancer, homogenized [OPG study]8.3722284
GSM549103patient 117, normal, homogenized [OPG study]6.7994870
GSM549117patient 073, normal, homogenized [OPG study]7.2977675
GSM549138patient 041, cancer, homogenized [OPG study]8.2324783
GSM549141patient 045, cancer, homogenized [OPG study]8.0122880
GSM549130patient 028, cancer, homogenized [OPG study]8.4987486
GSM549101patient 111, normal, homogenized [OPG study]7.2974775
GSM549105patient 128, normal, homogenized [OPG study]7.3909576
GSM549106patient 134, normal, homogenized [OPG study]7.4536975
GSM549112patient 048, normal, homogenized [OPG study]7.5177877
GSM549125patient 011, cancer, homogenized [OPG study]8.2427684
GSM549127patient 024, cancer, homogenized [OPG study]7.5910877
GSM549135patient 035, cancer, homogenized [OPG study]8.50985